Market Tracker

11/21 4:56am ET

Immunomedics Inc (NASDAQ:IMMU)

11.58
Delayed Data
As of Nov 20
 -0.17 / -1.45%
Today’s Change
3.01
Today|||52-Week Range
14.48
+215.53%
Year-to-Date

Today’s Trading

Previous close11.75
Today’s open11.75
Day’s range11.41 - 12.07
Volume2,492,954
Average volume (3 months)2,771,581
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+27.21%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp+0.44+1.16%
--Quidel Corp-0.63-1.95%
MYGNMyriad Genetics Inc-0.22-0.67%
----
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer-
Designee
Michael Pehl
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts